Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.9M Sell
738,473
-9,145
-1% -$1.07M 1.08% 19
2026
Q1
$89.9M Sell
747,618
-19,353
-3% -$2.23M 1.12% 18
2025
Q4
$80.7M Buy
766,971
+7,847
+1% +$737K 1.01% 25
2025
Q3
$63.7M Buy
759,124
+24,910
+3% +$2.05M 0.83% 30
2025
Q2
$58.1M Buy
+734,214
New +$58.4M 0.8% 31

Other funds holding MRK

Midwest Trust's MRK Position: Q2 2026 in Review

Midwest Trust reduced its Merck (MRK) stake by 1.2% in Q2 2026, selling an estimated $1.07M and leaving 738,473 shares worth $94.9M. The position accounts for 1.08% of the portfolio, ranked #19.

Midwest Trust first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Midwest Trust held 738,473 shares of Merck worth $94.9M as of Q2 2026.
  • Midwest Trust sold 9,145 Merck shares in Q2 2026, an estimated $1.07M.
  • Merck made up 1.08% of Midwest Trust's portfolio in Q2 2026, its #19 holding.
  • Midwest Trust first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.